Skip to main content

and
  1. Article

    Open Access

    Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study

    Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) primarily relies on FOLFIRINOX (LV5FU- irinotecan – Oxaliplatine) and Gemcitabine – Nab-Paclitaxel in the first-line setting. However, second-lines ...

    A. Gueiderikh, A. Tarabay, M. Abdelouahab, C. Smolenschi, M. L. Tanguy in BMC Cancer (2024)